183 related articles for article (PubMed ID: 10649985)
1. Carbonic anhydrase inhibitors: synthesis of membrane-impermeant low molecular weight sulfonamides possessing in vivo selectivity for the membrane-bound versus cytosolic isozymes.
Scozzafava A; Briganti F; Ilies MA; Supuran CT
J Med Chem; 2000 Jan; 43(2):292-300. PubMed ID: 10649985
[TBL] [Abstract][Full Text] [Related]
2. Carbonic anhydrase inhibitors: synthesis of sulfonamides incorporating 2,4,6-trisubstituted-pyridinium-ethylcarboxamido moieties possessing membrane-impermeability and in vivo selectivity for the membrane-bound (CA IV) versus the cytosolic (CA I and CA II) isozymes.
Supuran CT; Scozzafava A; Ilies MA; Briganti F
J Enzyme Inhib; 2000; 15(4):381-401. PubMed ID: 10995069
[TBL] [Abstract][Full Text] [Related]
3. Benzolamide is not a membrane-impermeant carbonic anhydrase inhibitor.
Supuran CT; Scozzafava A
J Enzyme Inhib Med Chem; 2004 Jun; 19(3):269-73. PubMed ID: 15499999
[TBL] [Abstract][Full Text] [Related]
4. Carbonic anhydrase inhibitors. Design of selective, membrane-impermeant inhibitors targeting the human tumor-associated isozyme IX.
Casey JR; Morgan PE; Vullo D; Scozzafava A; Mastrolorenzo A; Supuran CT
J Med Chem; 2004 Apr; 47(9):2337-47. PubMed ID: 15084132
[TBL] [Abstract][Full Text] [Related]
5. Carbonic anhydrase inhibitors. Schiff bases of some aromatic sulfonamides and their metal complexes: towards more selective inhibitors of carbonic anhydrase isozyme IV.
Popescu A; Simion A; Scozzafava A; Briganti F; Supuran CT
J Enzyme Inhib; 1999; 14(6):407-23. PubMed ID: 10536875
[TBL] [Abstract][Full Text] [Related]
6. Carbonic anhydrase inhibitors. Arylsulfonylureido- and arylureido-substituted aromatic and heterocyclic sulfonamides: towards selective inhibitors of carbonic anhydrase isozyme I.
Scozzafava A; Supuran CT
J Enzyme Inhib; 1999; 14(5):343-63. PubMed ID: 10488246
[TBL] [Abstract][Full Text] [Related]
7. Carbonic anhydrase inhibitors. Synthesis of water-soluble, topically effective, intraocular pressure-lowering aromatic/heterocyclic sulfonamides containing cationic or anionic moieties: is the tail more important than the ring?
Scozzafava A; Menabuoni L; Mincione F; Briganti F; Mincione G; Supuran CT
J Med Chem; 1999 Jul; 42(14):2641-50. PubMed ID: 10411484
[TBL] [Abstract][Full Text] [Related]
8. Carbonic anhydrase inhibitors: synthesis of water-soluble, topically effective intraocular pressure lowering aromatic/heterocyclic sulfonamides containing 8-quinoline-sulfonyl moieties: is the tail more important than the ring?
Borras J; Scozzafava A; Menabuoni L; Mincione F; Briganti F; Mincione G; Supuran CT
Bioorg Med Chem; 1999 Nov; 7(11):2397-406. PubMed ID: 10632049
[TBL] [Abstract][Full Text] [Related]
9. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides derived from 4-isothiocyanato-benzolamide.
Cecchi A; Winum JY; Innocenti A; Vullo D; Montero JL; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2004 Dec; 14(23):5775-80. PubMed ID: 15501039
[TBL] [Abstract][Full Text] [Related]
10. Carbonic anhydrase inhibitors: sulfonamides as antitumor agents?
Supuran CT; Briganti F; Tilli S; Chegwidden WR; Scozzafava A
Bioorg Med Chem; 2001 Mar; 9(3):703-14. PubMed ID: 11310605
[TBL] [Abstract][Full Text] [Related]
11. Carbonic anhydrase inhibitors. Inhibition of cytosolic isozyme XIII with aromatic and heterocyclic sulfonamides: a novel target for the drug design.
Lehtonen JM; Parkkila S; Vullo D; Casini A; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2004 Jul; 14(14):3757-62. PubMed ID: 15203157
[TBL] [Abstract][Full Text] [Related]
12. Carbonic anhydrase inhibitors. Inhibition of the membrane-bound human and bovine isozymes IV with sulfonamides.
Innocenti A; Firnges MA; Antel J; Wurl M; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2005 Feb; 15(4):1149-54. PubMed ID: 15686931
[TBL] [Abstract][Full Text] [Related]
13. Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX.
Garaj V; Puccetti L; Fasolis G; Winum JY; Montero JL; Scozzafava A; Vullo D; Innocenti A; Supuran CT
Bioorg Med Chem Lett; 2005 Jun; 15(12):3102-8. PubMed ID: 15905091
[TBL] [Abstract][Full Text] [Related]
14. Carbonic anhydrase inhibitors. Synthesis, molecular structures, and inhibition of the human cytosolic isozymes I and II and transmembrane isozymes IX, XII (cancer-associated) and XIV with novel 3-pyridinesulfonamide derivatives.
Brzozowski Z; Sławiński J; Gdaniec M; Innocenti A; Supuran CT
Eur J Med Chem; 2011 Sep; 46(9):4403-10. PubMed ID: 21820216
[TBL] [Abstract][Full Text] [Related]
15. Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with aromatic and heterocyclic sulfonamides.
Vullo D; Franchi M; Gallori E; Pastorek J; Scozzafava A; Pastorekova S; Supuran CT
Bioorg Med Chem Lett; 2003 Mar; 13(6):1005-9. PubMed ID: 12643899
[TBL] [Abstract][Full Text] [Related]
16. Carbonic anhydrase inhibitors: synthesis and inhibition of the human cytosolic isozymes I and II and transmembrane isozymes IX, XII (cancer-associated) and XIV with 4-substituted 3-pyridinesulfonamides.
Brzozowski Z; Sławiński J; Saczewski F; Innocenti A; Supuran CT
Eur J Med Chem; 2010 Jun; 45(6):2396-404. PubMed ID: 20202722
[TBL] [Abstract][Full Text] [Related]
17. Carbonic anhydrase inhibitors: synthesis of water-soluble, aminoacyl/dipeptidyl sulfonamides possessing long-lasting intraocular pressure-lowering properties via the topical route.
Scozzafava A; Briganti F; Mincione G; Menabuoni L; Mincione F; Supuran CT
J Med Chem; 1999 Sep; 42(18):3690-700. PubMed ID: 10479300
[TBL] [Abstract][Full Text] [Related]
18. Carbonic anhydrase inhibitors: the first selective, membrane-impermeant inhibitors targeting the tumor-associated isozyme IX.
Pastorekova S; Casini A; Scozzafava A; Vullo D; Pastorek J; Supuran CT
Bioorg Med Chem Lett; 2004 Feb; 14(4):869-73. PubMed ID: 15012984
[TBL] [Abstract][Full Text] [Related]
19. Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isozyme VII with aromatic and heterocyclic sulfonamides.
Vullo D; Voipio J; Innocenti A; Rivera C; Ranki H; Scozzafava A; Kaila K; Supuran CT
Bioorg Med Chem Lett; 2005 Feb; 15(4):971-6. PubMed ID: 15686895
[TBL] [Abstract][Full Text] [Related]
20. Carbonic anhydrase inhibitors. Water-soluble, topically effective intraocular pressure lowering agents derived from isonicotinic acid and aromatic/heterocyclic sulfonamides: is the tail more important than the ring?
Menabuoni L; Scozzafava A; Mincione F; Briganti F; Mincione G; Supuran CT
J Enzyme Inhib; 1999; 14(6):457-74. PubMed ID: 10536879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
